A bankruptcy judge has cleared the sale of 23andMe to the TTAM Research Institute, a nonprofit led by co-founder Anne Wojcicki, avoiding a problematic transfer of customer DNA data to Regeneron Pharmaceuticals. The deal was prompted by substantial opposition from several states that raised concerns about the unique nature of genetic information. With 80% of customers agreeing to research usage, the sale aims to advance medical research while improving privacy protections. The judge noted that the current agreement maintains customer control over their genetic data, crucial in the context of the original bankruptcy auction.
A bankruptcy judge has approved the sale of 23andMe to a nonprofit run by co-founder Anne Wojcicki, averting a controversial transfer of DNA data.
The sale avoids concerns over genetic data being sold to the highest bidder, as 80% of customers agree to share their information for research.
Collection
[
|
...
]